Agile Therapeutics, Inc. (AGRX)
OTCMKTS: AGRX · Delayed Price · USD
0.340
-0.030 (-8.11%)
Mar 28, 2024, 3:58 PM EDT - Market closed
Agile Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year | Current | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 2012 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Capitalization | 1 | 4,206 | 5 | 47 | 243 | 124 | 20 | 83 | 161 | 215 | 70 | Upgrade
|
Market Cap Growth | - | 85929.57% | -89.68% | -80.51% | 96.66% | 525.25% | -76.25% | -48.35% | -25.00% | 207.15% | 39.88% | Upgrade
|
Enterprise Value | 1 | - | 2 | 46 | 245 | 89 | 12 | 58 | 128 | 196 | 45 | Upgrade
|
PE Ratio | -323.43 | -290.74 | -0.19 | -0.62 | -4.44 | -6.70 | -1.00 | -2.94 | -5.61 | -7.08 | -4.35 | Upgrade
|
PS Ratio | 0.06 | 214.65 | 0.45 | 11.55 | 324.48 | - | - | - | - | - | - | Upgrade
|
PB Ratio | -354.16 | 0 | -0.88 | 5.11 | 4.93 | 2.70 | 0.98 | 2.29 | 3.81 | 7.22 | 1.94 | Upgrade
|
P/FCF Ratio | -592.79 | -116.56 | -0.07 | -0.99 | -15.39 | -7.18 | -0.76 | -3.57 | -6.25 | -14.72 | -3.89 | Upgrade
|
P/OCF Ratio | -592.79 | -116.99 | -0.07 | -1.00 | -15.49 | -7.31 | -0.80 | -3.57 | -6.33 | -14.82 | -5.37 | Upgrade
|
EV/Sales Ratio | 0.04 | - | 0.17 | 11.22 | 327.23 | - | - | - | - | - | - | Upgrade
|
EV/EBITDA Ratio | -292.73 | - | -0.04 | -0.65 | -5.03 | -4.80 | -0.66 | -2.18 | -4.32 | -5.92 | -2.41 | Upgrade
|
EV/EBIT Ratio | -288.55 | - | -0.04 | -0.65 | -5.01 | -4.79 | -0.66 | -2.18 | -4.32 | -5.92 | -2.41 | Upgrade
|
EV/FCF Ratio | -592.75 | - | -0.03 | -0.97 | -15.53 | -5.19 | -0.46 | -2.48 | -4.98 | -13.43 | -2.48 | Upgrade
|
Debt / Equity Ratio | -0.13 | 0 | -0.40 | 1.92 | 0.33 | 0.00 | 0 | 0.29 | 0.38 | 0.52 | 0.41 | Upgrade
|
Debt / EBITDA Ratio | -0.11 | -0.11 | -0.43 | -0.23 | 0.00 | - | -0.58 | -0.60 | -0.52 | -0.45 | -0.80 | Upgrade
|
Debt / FCF Ratio | -0.22 | -0.06 | -0.27 | -0.35 | -0.01 | - | -0.41 | -0.69 | -0.60 | -1.02 | -0.83 | Upgrade
|
Quick Ratio | 0.29 | 0 | 0.64 | 0.71 | 7.53 | 9.09 | 3.54 | 2.52 | 4.57 | 4.34 | 4.47 | Upgrade
|
Current Ratio | 0.46 | 0 | 0.85 | 0.82 | 7.72 | 9.31 | 3.81 | 2.57 | 4.82 | 4.80 | 4.56 | Upgrade
|
Asset Turnover | 1.68 | 0 | 0.76 | 0.10 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Interest Coverage | 13.32 | 14.01 | -13.23 | -18.14 | -15.78 | 0 | -17.50 | -13.98 | -12.76 | -15.97 | -11.85 | Upgrade
|
Return on Equity (ROE) | 77.74% | 260.87% | -274.10% | -155.26% | -119.55% | -91.42% | -54.45% | -66.93% | -96.63% | -84.25% | 22.50% | Upgrade
|
Return on Assets (ROA) | -123.70% | -101.57% | -64.61% | -104.82% | -110.39% | -82.36% | -39.09% | -44.32% | -56.67% | -55.33% | -111.61% | Upgrade
|
Return on Capital (ROIC) | 140.56% | 596.40% | -153.10% | -107.83% | -106.83% | -93.48% | -41.63% | -45.99% | -65.66% | -65.09% | 32.73% | Upgrade
|
Earnings Yield | -1083.59% | -0.34% | -519.82% | -161.67% | -22.50% | -14.92% | -100.07% | -34.01% | -17.83% | -14.12% | -22.98% | Upgrade
|
FCF Yield | -832.79% | - | -738.05% | -138.21% | -19.61% | -12.77% | -87.09% | -31.09% | -14.48% | -11.99% | -20.87% | Upgrade
|
Buyback Yield / Dilution | -359283.18% | -498890.32% | -790.51% | -14.63% | -71.31% | -44.06% | -10.90% | -9.44% | -28.42% | -93.22% | -16.93% | Upgrade
|
Total Shareholder Return | -359283.18% | -498890.32% | -790.51% | -14.63% | -71.31% | -44.06% | -10.90% | -9.44% | -28.42% | -93.22% | -16.93% | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.